OTCMKTS:GSTC GlobeStar Therapeutics (GSTC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About GlobeStar Therapeutics Stock (OTCMKTS:GSTC) 30 days 90 days 365 days Advanced Chart Get GlobeStar Therapeutics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume8,020 shsAverage Volume8,020 shsMarket Capitalization$120 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.Read More… Receive GSTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GSTC Stock News HeadlinesGlobeStar Therapeutics Corporat (GSTC) stock forecast and price targetJanuary 23, 2025 | finance.yahoo.comCompare with GlobeStar Therapeutics Corp (GSTC)May 29, 2024 | msn.com"I'm risking my reputation on this"What the headlines won't tell you: Smart money was positioned before both events. They didn't react to news—they anticipated it. How? They follow patterns. Market cycles. Institutional flows. The same patterns we document in Crypto Revolution and the next pattern is forming now.June 28 at 2:00 AM | Crypto 101 Media (Ad)GlobeStar Therapeutics Corporation: Globestar Therapeutics Update on Project Amethyst and Recent FinancialsMarch 28, 2024 | finanznachrichten.deKHTRF Knight Therapeutics Inc.December 20, 2023 | seekingalpha.comGlobeStar Therapeutics Corp GSTCDecember 14, 2023 | morningstar.comMGlobeStar signs deal with Advanced Innovative to develop clinical studies for MS treatmentNovember 4, 2023 | msn.comGlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis TreatmentNovember 2, 2023 | finance.yahoo.comSee More Headlines GSTC Stock Analysis - Frequently Asked Questions How do I buy shares of GlobeStar Therapeutics? Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GlobeStar Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that GlobeStar Therapeutics investors own include Arrival (ARVL), Cosmos Health (COSM), COMSovereign (COMS), Good Hemp (GHMP), Meta Materials (MMTLP), Palisade Bio (PALI) and Sintx Technologies (SINT). Company Calendar Today6/28/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:GSTC CIK1502152 Webangiosoma.com Phone(206) 451-1970FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,241,110,000Free Float1,210,078,000Market Cap$120 thousand OptionableNot Optionable Beta2.55 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:GSTC) was last updated on 6/28/2025 by MarketBeat.com Staff From Our PartnersCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored"I'm risking my reputation on this"What the headlines won't tell you: Smart money was positioned before both events. They didn't react to news...Crypto 101 Media | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Knows Exactly What He’s Doing…With Trump in office, new money is flowing in and out of the market like never before... And some folks usi...Brownstone Research | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlobeStar Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share GlobeStar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.